Prana Biotechnology Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 89   

Articles published

PRAN 1.19 +0.02 (1.71%)
price chart
Traders Stocks Alert: Prana Biotechnology Limited (ADR) (NASDAQ:PRAN ...
Lakeway, NY - (MARKET NEWS CALL) - 04/28/2015� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
What's Hurting These 3 Stocks? � Prana Biotechnology Limited (ADR) (NASDAQ ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) sank 70.49% early Monday after the Australian drug developer said its most advanced potential treatment failed to meet the main goal in a study of patients with Alzheimer's disease.
Related articles »  
Prana Biotechnology Limited (ADR) (PRAN) news: Prana: Right Drug, Wrong Dose
Prana Biotechnology Limited (NASDAQ:PRAN) is expected to release the results from its Phase 2b IMAGINE trial of PBT2 for the treatment of Alzheimer's disease within the coming month.
Should You Invest In Prana Biotechnology Limited (PRAN), IsoRay, Inc.(ISR ...
Prana Biotechnology Limited (ADR)(NASDAQ:PRAN) lost $1.09 to finish the day at a closing price of $1.09. The 33.54% decline in value came on a day when the stock traded for as little as $1.07, a new 52 week low for Melbourne-based biotechnology ...
Prana Biotechnology Limited (ADR) (PRAN) news: Prana Biotech -13% as ...
Prana is working under a different hypothesis. It, along with a growing number of scientists, now think that small beta-amyloid oligomers are the real culprits in Alzheimer's disease, because they have been found to float into synapses and short ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) Falls On Fears  GSPInsider
Prana Biotechnology (PRAN) Stock Declines; Summer Street Not Impressed with ...  StreetInsider.com (subscription)
Related articles »  
Prana Biotechnology Limited (ADR) (PRAN) news: Prana Biotechnology - A ...
One company in particular, Prana Biotechnology (NASDAQ:PRAN), is well-positioned to address this market with their lead drug, and in a realistic but optimistic scenario, the share price could ducuple (increase by 10 times) by the end of the month.
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN): The Research Programs ...
Boston, MA, 04/09/2014 (usastockreport) - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announces issue of ordinary shares to carry out its business proceeds.
Related articles »  
Investor News: IsoRay Inc. (NYSEMKT:ISR), Prana Biotechnology Limited (ADR ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) American depositary shares edged higher Monday, as the therapeutic-drugs developer's stock extended a recent climb from its 52-week low.
Why Prana Biotechnology Limited soared 33% today
Biotech company Prana Biotechnology Limited (ASX: PBT) saw its shares soar 33% to 22 cents in trading today, following similar gains (21%) in its NASDAQ-listed shares overnight.
Related articles »  
Prana Biotechnology Limited (ADR) (PRAN) news: Alzheimer's Dementia: Eli ...
In this article I will be analyzing the differences between Eli Lilly's (NYSE:LLY) Solanezumab and Prana Biotechnology's (NASDAQ:PRAN) PBT2 -- the new leading candidates in the treatment of Alzheimer's dementia and the implications for their ...